Metraipolis › archive › dc_94d2aa8d775b

Enhanced immunogenicity of COVID-19 RBD fused to mutant scorpion's phospholipase D for vaccine development — Europe PMC PMID:40980200

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40980200
DOI
10.1016/j.nmni.2025.101634
License (as archived)
solo-consultazione
Archived
2026-11-10T04:40:09.500Z
SHA-256 of the archived text
67ff1589d7a631da59f7d660b30a375fbdca49741aaa5e3b5dc156a219428381
Stable URL of this page
https://metraipolis.com/documento/dc_94d2aa8d775b

How to cite

Enhanced immunogenicity of COVID-19 RBD fused to mutant scorpion's phospholipase D for vaccine development — Europe PMC PMID:40980200 — Europe PMC (en), https://europepmc.org/article/MED/40980200 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_94d2aa8d775b (Metraipolis archive dc_94d2aa8d775b, sha256 67ff1589d7a631da59f7d660b30a375fbdca49741aaa5e3b5dc156a219428381)
BibTeX
@misc{dc94d2aa8d775b,
  title = {Enhanced immunogenicity of COVID-19 RBD fused to mutant scorpion's phospholipase D for vaccine development — Europe PMC PMID:40980200},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40980200},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_94d2aa8d775b; sha256 67ff1589d7a631da59f7d660b30a375fbdca49741aaa5e3b5dc156a219428381},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40980200. Agents can read the archived copy with the MCP tool read_document.